Intrapace Company

IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Health Diagnostics
Headquarters: San Jose, California, United States
Founded Date: 2001-01-01
Employees Number: 11-50
Investors Number: 10
Total Funding: $192.9M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership